Plant People.

There is a shelf at Target - one of 820-odd of them, in fact - where a resealable pouch of raspberry-flavored gummies promises eight mushrooms, zero sugar, and a slightly better afternoon. The pouch belongs to Plant People. Getting it onto that shelf took about seven years, two recovering spinal patients, and a stubborn refusal to follow the usual startup script.

Plant People is, today, a functional-wellness brand with a tidy obsession: making plant-based supplements people can actually feel, and then proving it. Its catalog reads like a weather forecast for the human body - WonderDay for energy, WonderSleep for the obvious, WonderFocus for the 3 p.m. fog, WonderCalm for everything else. The company is a Certified B Corporation, headquartered in the Austin area, and run by two founders who met, of all places, on a hike.

It is the kind of company that, in 2026, looks almost suspiciously sensible. No moonshot. No burn-the-furniture growth. Just a product line, a profit, and a recently signed term sheet. That sensibility is the whole story - and to appreciate it, you have to understand the problem the founders set out to fix.

The problem they saw

A supplement aisle nobody trusted

The functional-wellness aisle has long had a credibility problem. Plenty of bottles, plenty of bold claims, not much you could verify. Mushrooms in particular got swept up in a tide of marketing that ran well ahead of the science - dust of unknown origin, dosages no one disclosed, and an industry-wide habit of selling mycelium-on-grain while implying you were getting the actual mushroom.

Into that skepticism walked two people who had reason to care more than most. Hudson Gaines-Ross, a consumer-products operator who had already helped build brands like RISE Brewing and ALOHA, and Gabe Kennedy, a trained chef from a family of alternative-medicine practitioners. Both were recovering from back surgery when they met hiking around 2016. Both had run out of patience with the gap between wellness promises and wellness proof.

The founders' bet

Build it slow, build it real

The bet was unfashionable: skip the venture-fueled land grab and build a profitable business first. The earliest formulas were developed in Hudson's New York apartment, with guidance from Gabe's parents - an acupuncturist and a chiropractor - and sold, at first, door-to-door to local shops. There was no growth-hacking deck. There was a backpack and a list of stores.

The discipline showed up in the numbers. By the company's own account, Plant People ran for roughly seven years with minimal outside capital, growing revenue at a clip most venture-backed peers would envy - while staying in the black. In an industry that loves to confuse fundraising with success, that is a quiet kind of rebellion.

The product

Eight mushrooms, no sugar, one habit

The flagship is WonderDay: a daily gummy packing eight functional mushrooms - Lion's Mane, Chaga, Reishi, Turkey Tail, Royal Sun, Cordyceps and friends - at 5,000mg per serving, made with 100% fruiting body and a 10:1 extract. It is vegan, gluten-free, top-eight-allergen-free, and free of the usual suspects: high-fructose corn syrup, food dyes, seed oils. The flavor is chef-crafted wild raspberry, which is to say someone actually thought about whether you'd want a second one.

The strategy is less about any single hero product and more about format. Capsules feel like medicine; powders feel like homework. A gummy feels like a treat you can build a habit around - which, for a daily supplement, is the entire game. Plant People bet that the easiest wellness routine is the one you don't have to think about, and then made it taste good enough that you wouldn't.

The proof

The receipts

Plenty of brands talk transparency. Plant People keeps a scoreboard. More than 100 million gummies sold. A network of 4,500-plus clinicians who recommend the products. Lab-tested formulas, NSF and GMP compliance, Made in USA, and a B Corp impact score reported around 88. The press cabinet holds The New York Times, Forbes, Vogue and goop. None of it is shouted; all of it is checkable.

The proof convinced the people whose job is to be unconvinced. In November 2025, Manna Tree Partners led Plant People's Series A - a strategic minority stake - with early backer Unilever Ventures joining in. Manna Tree's co-founder, by her own account, had been a customer long before she was an investor, which is roughly the highest compliment a consumer brand can receive.

The mission

A public benefit, on paper and otherwise

Plant People is structured as a Public Benefit Corporation - "Plant People, PBC" - which means the mission is not just a slogan in the footer. The company leans climate-conscious, plant-based, and recycled-where-possible, and the founders are blunt about wanting employees who feel like owners. The line they repeat is that each hire should have ownership and feel like a key decision-maker. It is a small thing that tends to show up in the product.

Why it matters tomorrow

The shelf, revisited

Back to that Target shelf. A few years ago it would have held a row of bottles making promises and a customer squinting at the back, trying to figure out which ones were real. The squint was the problem. Plant People's whole project is to make the squint unnecessary - to sell a daily habit that's pleasant enough to keep and honest enough to trust.

Whether functional mushrooms turn out to be a lasting category or a passing craze, the more interesting bet is the one on how to build: slowly, profitably, and in public benefit form, with the receipts kept where anyone can check them. That is the unfashionable thing Plant People did. It worked. And now there's a pouch of raspberry gummies on a shelf in 820 stores to prove it.

Notes: Some dates (founding year in particular) and dollar figures are reported by the company or single sources and are marked approximate where noted. Growth percentages are company-reported and self-disclosed. Where details could not be independently verified, they have been left out.